Various studies have shown that clonidine can be used as a sole analgesic agent in intrathecal anesthesia and as an adjuvant to local anesthetics in peripheral nerve blocks. [11] [12] [13] [14] However, the reports of its use in supraclavicular brachial plexus block along with ropivacaine are limited. In this study, we investigated whether adding clonidine to ropivacaine for supraclavicular brachial plexus block would aff ect the degree of sensory and motor blockade and duration of analgesia.
Materials and Methods
This study was conducted in the Department of Anesthesia, at Tertiary Care Center. This prospective, randomized, double-blind, study included 80 patients, of ASA Grade I and II, age 20-50 years, body weight 50-80 kg who underwent elective surgery in upper limb. Prior ethical permission was taken from our institutional ethical committee.
Patients who had local pathology at the site of injection or disability, history of convulsion, allergy to the drugs used, bleeding disorders, uncooperative and with severe neurological deficit were excluded from the study.
Preanesthetic checkup (PAC) was done the day before the surgery that included a complete history of the patient including any known drug allergy, general and systemic examination and local examination of supraclavicular area. Pulse rate, blood pressure, respiratory rate and weight of the patient were noted. Routine relevant investigations were done in all the patients.
Informed consent was obtained for performance of brachial plexus block after complete explanation about the study protocol and the procedure. Visual analogue scale (VAS) 0-10 was explained to the patient.
The patients were randomized on the day of surgery into two groups each of 40 patients by chit in box method. Patients themselves used to take out the chit from the box. Medications were prepared by one anesthetist and observations were made by another anesthetist. In Group 1, 40 patients received 28 ml of 0.5% ropivacaine and in Group 2, 40 patients received 28 ml of 0.5% ropivacaine with clonidine (2 μg/kg body weight). All the solutions were diluted with normal saline to make a total volume of 30 ml.
Fasting status, consent, PAC were checked, and intravenous access was secured in all the patients. Perioperative sedation was achieved by using midazolam 1 mg intravenously. The patient was placed in the supine position, with the head turned away, and the ipsilateral arm adducted. The interscalene groove and mid-point of the clavicle and subclavian artery was identifi ed. After aseptic preparation of the area, at a point 1.5-2.0 centimeter posterior to the midpoint of the clavicle, a skin wheal was raised with a local anesthetic (lignocaine 2% plain). Next, a 22 gauge, 50 mm "short bevelled" needle was passed through the same point in a caudal, slightly medial and posterior direction, until either a paresthesia was elicited or the fi rst rib was encountered. If the fi rst rib was encountered, the needle was moved over the fi rst rib until a paresthesia was elicited either in the hand or arm. After eliciting paresthesia and negative aspiration of blood, the study medication was injected.
Patients were evaluated for onset of sensory block every 1 min. The sensory block was assessed by pin prick with 25 gauge needle in C5-6 dermatome. The onset time of the sensory block was taken as the time interval in minutes from min-0 till the sensory block started appearing that is, score >1 [ Table 1 ].
Motor blockade was assessed using Modifi ed Bromage scale (MBS) [15] [ Table 2 ]. The onset time of the motor block, that is, MBS score = 1 was also recorded in all cases.
Heart rate, non-invasive blood pressure and Oxygen saturation (SpO 2 ) were recorded every 5 min for fi rst ½ h and thereafter every 15 min. Intraoperative sedation was assessed by using a four-point scale [ Table 3 ]. [16] Postoperatively heart rate, noninvasive blood pressure and pain and motor power were recorded at 0 min, 30 min, 1 h, 3 h, 6 h, 12 h and 24 h. VAS score was measured at 6 h, 12 h and 18 h [Table 6a ]. Partial block-total forearm and partial arm fl exion 2
Almost complete block-inability to fl ex the arm and decreased ability to fl ex the forearm 3
Total block-inability to fl ex both the arm and forearm
The duration of motor block was defi ned as the time taken for reversal to Bromage score 1.
Rescue analgesia was given on patient's demand. Total duration of analgesia was defi ned as the time from injection of drug administration to the patient's fi rst request for rescue analgesic. Injection diclofenac 75 mg IV was given as rescue analgesic.
The sample size calculation was based on the previous study to determine the diff erence in outcome variable (R) of both anesthetic drugs at 95% confi dence interval, 5% alpha error and the power of study was 80%. To detect the minimum diff erence of 0.5 min (±0.8) in onset time of sensory and motor block of (median cutaneous nerve) the calculated sample size for each group was 40 patients using primer software.
Statistical analysis was performed with SPSS, version 15.0, for Windows statistical software package (SPSS inc., Chicago, IL, USA). Categorical data, that is, ASA grade, type of surgery and the incidence of adverse events (hypotension, bradycardia, dryness of mouth, nausea, vomiting and headache) were presented as % and proportions. These data were compared in two groups and the diff erence in the proportion was inferred by Chisquare test. Demographic data (age, weight), duration of surgery, VAS score, total duration of motor block and analgesia were expressed as mean ± standard deviation. These data were compared in two groups and diff erences in means were inferred by unpaired t-test. For signifi cance P < 0.05 was considered as signifi cant for both types of data.
Results
It was observed that the mean age, body weight, ASA grading and duration of surgery were similar in both the groups and no statistically signifi cant diff erence was present [ Table 4 ]. The mean onset of sensory and motor blockade was comparable in both the groups [ Table 5 ].
Thirty-two out of 40 patients in Group 1 and 34 out of 40 patients in Group 2 had sensory blockade of Grade 2. Eight patients in Group 1 and six patients in Group 2 had only touched sensation and no response to any painful stimulus (Grade 1 sensory blockade).
33 patients in Group 1 and 34 patients in Group 2 showed complete motor blockade (Grade 3) with inability to fl ex the arm and forearm while seven in Group 1 and six in Group 2 were able to fl ex the forearm but unable to fl ex the arm (Grade 2).
The mean duration of analgesia and duration of motor block was more in Group 2 as compared to Group 1. It was statistically signifi cant (P < 0.000) [ Table 5 ].
In Group 1, all the patients were opening eyes spontaneously.
In Group 2 four out of 40 had sedation score 2.
Group 1 showed more severity of pain than Group 2 and it was found to be statistically signifi cant (P < 0.001) [ Table 6b ]. There were no significant differences between groups regarding the incidence of perioperative adverse eff ects.
Discussion
In the present study, brachial plexus blockade was achieved by classical supraclavicular approach and satisfactory surgical anesthesia was attained in all the cases for various types of upper limb surgeries. Clonidine, when added to ropivacaine, was found to be superior to ropivacaine alone. Effect of clonidine, when added to ropivacaine, is controversial in the literature. In some studies adding clonidine to ropivacaine found to be synergistic and in others it did not the prolong duration of brachial plexus block. In one study of axillary brachial plexus block, clonidine (1 μg/kg) when added to 20 ml of ropivacaine 0.75% led to sensory analgesia that lasted for 15.2 h compared to 13.8 h in ropivacaine alone. [13] In an another study duration of motor blockade was 721 ± 38 min and sensory anaesthesia was 828 ± 35 min when 150 μg of clonidine was added to 40 ml of 0.75% of ropivacaine compared to 552 ± 35 min motor block and 587 ± 40 min sensory anaesthesia in control group. [17] Duration and quality of analgesia provided by an interscalene brachial plexus block (n = 30) for shoulder surgery by adding 40 μg of clonidine to 200 mg of 0.5% ropivacaine didn't prolong the sensory-motor block or improve the quality of analgesia in the early postoperative period. [16] Similarly, adding clonidine with ropivacaine did not improve overall postoperative analgesia but may increase the time to the fi rst analgesia request in a study of 60 pediatric axillary brachial plexus blocks. [15] Addition of clonidine has a diff erent impact on diff erent local anesthetics in terms of onset and duration of block. Clonidine has been found to the prolong duration of motor blockade in the mepivacaine and bupivacaine groups, but not in the ropivacaine group. [18] Same author earlier also found that the addition of clonidine to ropivacaine didn't lead to any advantage of block of the brachial plexus when compared with pure ropivacaine 0.75%. [19] None of the studies has found signifi cant sedation and cardiovascular side eff ects.
The mechanism of action of clonidine in peripheral nerve blocks is highly unclear. Clonidine blocks conduction of A delta and C fi bers with some preference for C fi bers and intensifi es the conduction of local anesthetics. Clonidine seems to exert a local action at the peripheral nerve because subcutaneous or intramuscular injection of clonidine did not increase the duration of block. [20] Controversial eff ect of clonidine with ropivacaine on anesthetic eff ect is unknown.
The present study didn't found clinically important diff erence in the haemodynamic parameters and adverse eff ects among the two groups. This may contribute to the fact that the doses of the drugs used in the study was appropriate and clonidine did not produce any adverse eff ects when used in peripheral nerve blocks.
Conclusions
Clonidine, when added to 0.5% ropivacaine in supraclavicular brachial plexus block for upper limb surgeries, resulted into signifi cant prolongation of sensory and motor block as compared to ropivacaine alone without any potential side eff ects. -3: No pain-mild pain  9  40  0  17  0  0  4-6: Moderate pain  28  0  19  22  8  29  7-10: Severe pain  3  0  21  1  32  11 VAS: Visual analog scale
